title: Reply to Z. Blumenfeld et al.
authors.affiliation: Université Libre de Bruxelles, Brussels, Belgium.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Demeestere
authors.forename: Pauline
authors.initials: P
authors.lastname: Brice
authors.forename: Fedro Alessandro
authors.initials: FA
authors.lastname: Peccatori
authors.forename: Alain
authors.initials: A
authors.lastname: Kentos
authors.forename: Isabelle
authors.initials: I
authors.lastname: Gaillard
authors.forename: Pierre
authors.initials: P
authors.lastname: Zachee
authors.forename: Olivier
authors.initials: O
authors.lastname: Casasnovas
authors.forename: Eric
authors.initials: E
authors.lastname: Van Den Neste
authors.forename: Julie
authors.initials: J
authors.lastname: Dechene
authors.forename: Vivianne
authors.initials: V
authors.lastname: De Maertelaer
authors.forename: Dominique
authors.initials: D
authors.lastname: Bron
authors.forename: Yvon
authors.initials: Y
authors.lastname: Englert
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004958:Estradiol / Q000097:blood*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D017697:Premenopause; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced* / Q000517:prevention & control*; D017329:Triptorelin Pamoate / Q000627:therapeutic use*
chemical_list: D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D005640:Follicle Stimulating Hormone